Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021

References

• World Health Organisation. Tuberculosis Fact Sheet Geneva: WHO; 2021 [cited 2022 May 25]. Available from: http://www.who.int/news-room/fact-sheets/detail/tuberculosis.
   Google Scholar
• International Diabetes Federation. Diabetic facts and figures Brussels, Belgium: IDF; 2021 [updated 09 December 2021; cited 2022 May 25]. Available from: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.
   Google Scholar
• World Health Organisation. Diabetes key facts Geneva: WHO; 2021 [updated 10 Nov 2021; cited 2022 May 25]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
   Google Scholar
• Faurholt‐Jepsen D, Range N, PrayGod G, et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania. Trop Med Int Health. 2013;18(7):822–11.
   PubMed Web of Science ®Google Scholar
• Jiménez-Corona ME, Cruz-Hervert LP, García-García L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013;68:214–220.
   PubMed Web of Science ®Google Scholar
• Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9(1):1–15.
   PubMedGoogle Scholar
• Root HF. The association of diabetes and tuberculosis. N Engl J Med. 1934;210(3):127–147.
   Google Scholar
• Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2· 3 million patients with tuberculosis. Lancet Glob Health. 2019;7:e448–e60.
   PubMed Web of Science ®Google Scholar
• Alebel A, Wondemagegn AT, Tesema C, et al. Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2019;19(1):1–10.
   PubMedGoogle Scholar
• Magee MJ, Salindri AD, Kyaw NTT, et al. Stress hyperglycemia in patients with tuberculosis disease: epidemiology and clinical implications. Curr Diab Rep. 2018;18(9):1–10.
   PubMed Web of Science ®Google Scholar
• Luies L, du Preez I. The echo of pulmonary tuberculosis: mechanisms of clinical symptoms and other disease-induced systemic complications. Clin Microbiol Rev. 2020;33(4). DOI:10.1128/CMR.00036-20
   PubMed Web of Science ®Google Scholar
• Cheng P, Wang L, Gong W. Cellular immunity of patients with tuberculosis combined with diabetes. J Immunol Res. 2022;2022. DOI:10.1155/2022/6837745
   Web of Science ®Google Scholar
• Krishnappa D, Sharma SK, Singh AD, et al. Impact of tuberculosis on glycaemic status: a neglected association. Indian J Med Res. 2019;149:384.
   PubMed Web of Science ®Google Scholar
• Başoğlu OK, Bacakoğlu F, Cok G, et al. The oral glucose tolerance test in patients with respiratory infections. Monaldi Archives for Chest Disease Archivio Monaldi per le Malattie Del Torace. 1999;54(4):307–310.
   PubMedGoogle Scholar
• Tabarsi P, Baghaei P, Marjani M, et al. Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study. J Diabetes & Metabolic Disord. 2014;13:1–6.
   PubMedGoogle Scholar
• Salindri AD, Wang J-Y, Lin -H-H, et al. Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002–2013. Inter J Infect Dis. 2019;84:127–130.
   PubMed Web of Science ®Google Scholar
• Pearson F, Huangfu P, Pearce M, et al. OP52 exploring the association between tuberculosis and diabetes in a UK primary care dataset. BMJ Publishing Group Ltd; 2016.
   Google Scholar
• Yorke E, Atiase Y, Akpalu J, et al. The bidirectional relationship between tuberculosis and diabetes. Tuberc Res Treat. 2017;2017:1702578.
   PubMedGoogle Scholar
• Oluboyo PO, Erasmus RT. The significance of glucose intolerance in pulmonary tuberculosis. Tubercle. 1990;71:135–138.
   PubMedGoogle Scholar
• Jawad F, Shem A, Memon R, et al. Glucose intolerance in pulmonary tuberculosis. J-Pakistan Med Assoc. 1995;45:237–238.
   PubMedGoogle Scholar
• Boillat-Blanco N, Ramaiya KL, Mganga M, et al. Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis. 2016;213(7):1163–1172.
   PubMed Web of Science ®Google Scholar
• Menon S, Francis J, Zdraveska N, et al. The epidemiology of intransient TB-induced hyperglycaemia in previously undiagnosed diabetes mellitus 2 individuals: a protocol for a systematic review and meta-analysis. Syst Rev. 2019;8:1–5.
   PubMed Web of Science ®Google Scholar
• Peters M, Godfrey C, McInerney P, et al. Joanna Briggs Institute reviewer’s manual: Adelaide, Australia: The Joanna Briggs Institute. 2017.
   Google Scholar
• Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
   Google Scholar
• Watson JM, Gill ON. HIV infection and tuberculosis. BMJ. 1990;300:63–65.
   PubMedGoogle Scholar
• Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? a meta-analysis. Diabetes Metab Syndr. 2020;14(4):535–545.
   PubMed Web of Science ®Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):1–10.
   PubMedGoogle Scholar
• Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
   PubMed Web of Science ®Google Scholar
• Purohit S, Gupta P, Agarwal K, et al. Glucose tolerance during rifampicin therapy. Ind J Tub. 1984;31:3.
   Google Scholar
• Singh M, Biswas S, Shah A. Impaired glucose tolerance in active pulmonary tuberculosis. Indian J Tuberc. 1984;31(3):118–121.
   Google Scholar
• Akinlade K, Rahamon S, Edem V, et al. Glycated haemoglobin levels in patients with multidrug-resistant tuberculosis infection during 6 months of treatment. Afr J Clin Exp Microbiol. 2016;17(3):173–178.
   Google Scholar
• Lin Y, Yuan Y, Zhao X, et al. The change in blood glucose levels in tuberculosis patients before and during anti-tuberculosis treatment in China. Glob Health Action. 2017;10:1289737.
   PubMed Web of Science ®Google Scholar
• Moreira J, Castro R, Lamas C, et al. Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil. Inter J Infect Dis. 2018;69:11–19.
   PubMed Web of Science ®Google Scholar
• Diarra B, Tolofoudie M, Sarro Y, et al. Diabetes Mellitus among new tuberculosis patients in Bamako, Mali. J Clin Tuberculosis Other Mycobacterial Dis. 2019;17:100128.
   PubMedGoogle Scholar
• Habib SS, Rafiq S, Jamal WZ, et al. Engagement of private healthcare providers for case finding of tuberculosis and diabetes mellitus in Pakistan. BMC Health Serv Res. 2020;20:1–8.
   Web of Science ®Google Scholar
• Kubjane M, Berkowitz N, Goliath R, et al. Tuberculosis, human immunodeficiency virus, and the association with transient hyperglycemia in periurban South Africa. Clin Infect Dis. 2020;71:1080–1088.
   PubMed Web of Science ®Google Scholar
• Association AD. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019;42((Supplement_1):S13):):.
   Google Scholar
• Wang J-Y, Lee L, Hsueh P. Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis. 2005;9(7):777–783.
   PubMed Web of Science ®Google Scholar
• Huangfu P, Ugarte-Gil C, Golub J, et al. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2019;23(7):783–796.
   PubMed Web of Science ®Google Scholar
• Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, et al. The effect of diabetes and prediabetes on antituberculosis treatment outcomes: a multicenter prospective cohort study. J Infect Dis. 2022;225(4):617–626.
   PubMed Web of Science ®Google Scholar
• Yorke E, Boima V, Dey ID, et al. Transient impact of dysglycemia on sputum conversion among smear-positive tuberculosis patients in a tertiary care facility in Ghana. Clin Med Insights: Circulatory, Respir and Pulm Med. 2021;15:11795484211039830.
   Web of Science ®Google Scholar
• Faurholt-Jepsen D, Range N, PrayGod G, et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PloS one. 2011;6(8):e24215.
   PubMed Web of Science ®Google Scholar
• Ekeke N, Ukwaja KN, Chukwu JN, et al. Screening for diabetes mellitus among tuberculosis patients in Southern Nigeria: a multi-centre implementation study under programme settings. Sci Rep. 2017;7(1):1–8.
   PubMedGoogle Scholar
• Munseri PJ, Kimambo H, Pallangyo K. Diabetes mellitus among patients attending TB clinics in Dar es Salaam: a descriptive cross-sectional study. BMC Infect Dis. 2019;19(1):1–8.
   PubMed Web of Science ®Google Scholar
• Oni T, Berkowitz N, Kubjane M, et al. Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control. Eur Respir J. 2017;50(1):1.
   Web of Science ®Google Scholar